VA106483 and Alpha Blocker Interaction Study in Elderly Males

NCT00879216 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: VA106483
DRUG: Placebo

Sponsor

Vantia Ltd